Named on one round in the feed.
Since 2026-10-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Soufflé Therapeutics, Inc. A leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives | Series B Verified against 1 of 3 sources | $135M | 2026-10-13 | [ PART ] |